Business Problem

Our client, one of the world's largest vaccine manufacturers was operating in one of the most high-stakes communications environments imaginable: the global rollout of their COVID-19 vaccine. In this context, misinformation, adverse event reports, and public sentiment could shift rapidly and at scale, with real-world consequences for both public health and the brand.

The client needed a partner who could provide 24/7 live monitoring and crisis alerting, with alerts raised within 20 minutes of any incident occurring anywhere in the world. This was not a periodic reporting requirement. It was a continuous, always-on intelligence operation covering:

•       Real-time tracking and alerting of their COVID-19 vaccine across all major digital and social channels.

•       Adverse event (AE) monitoring identifying and flagging reports of vaccine side effects as they appeared online.

•       Crisis detection surfacing emerging issues before they escalated into larger public health or reputational incidents.

•       Brand tracking and performance analysis alongside state-by-state rollout reporting.

Solution

We stood up a dedicated live alerting and reporting operation running 365 days a year, 24 hours a day without exception. Our team was configured to raise alerts within 20 minutes of an incident being detected, giving the client the response window they needed to act before a story gathered momentum.

Our monitoring covered the full digital landscape, social media, news media, forums, and other online sources, tracking conversations about the client's COVID-19 vaccine across multiple geographies simultaneously.

Key components of our solution included:

•       Adverse Event Tracking: systematic identification and categorization of posts reporting vaccine side effects, with clear escalation protocols for high-severity reports.

•       Crisis Alerting: real-time detection of emerging narratives, misinformation spikes, or incident reports, with immediate notification to the client's communications and medical affairs teams.

•       State-wise Rollout Reporting: granular tracking of public sentiment and conversation volumes tied to vaccine rollout milestones in specific US states, giving the client a geographic view of the narrative.

•       Brand Tracking and Performance Analysis: ongoing monitoring of how the client's vaccine brand was being discussed relative to competitors and the broader vaccine landscape.

•       Periodic and Wrap-Up Reporting: structured reports at regular intervals, plus specialized 'wrap up' reports that synthesized trends, incidents, and insights over defined time periods.

Benefits

Our client had the intelligence infrastructure they needed to operate confidently in a fast-moving, high-risk communications environment. Key outcomes included:

•       20-minute incident alerting: the client was consistently notified of emerging issues within the committed timeframe, enabling rapid internal escalation and response.

•       Comprehensive adverse event visibility: the client had a clear, continuously updated picture of how side effect conversations were evolving online, informing both medical affairs and communications decisions.

•       Crisis prevention: early detection of narrative spikes meant the client could intervene before issues became crises, rather than responding reactively.

•       Geographic intelligence: state-level rollout reporting gave the client actionable insight into regional sentiment variation, helping them tailor communications to specific markets.

•       An auditable intelligence record: periodic and wrap-up reporting created a documented timeline of the digital conversation around the vaccine rollout, valuable for internal review, regulatory context, and strategic planning.